NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Mercury Laboratories

BSE: 538964 22 Feb 2025
Healthcare
₹ 858.0
Mercury Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

Mercury Laboratories - Share Price & Details

Market Cap
₹103.0
High /Low
1,190 / 760.0
Stock P/E
26.1
Book Value
₹431.0
Dividend Yield
0.41
ROCE
13.4
ROE
₹11.6
Face Value
10.0
PEG Ratio
1.8
EVEBITDA
₹11.8
Debt
4.60
CMP / FCF
46.4
Debt to equity
₹0.09
NP Ann
5.65
High price all time
1,303
Piotroski score
₹8.0
Graham Number
564.0
No. Eq. Shares
0.12
Net CF
₹0.91
Net profit
3.94
Price to book value
1.99
Interest Coverage
₹11.5
Low price all time
32.5
Industry PE
35.4
Reserves
₹50.5
Free Cash Flow
₹1.96

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
Mercury Laboratories Limited195.729.9426.1
SOURCE NATURAL FOODS & HERBAL104.461.5838.2
BHARAT IMMUNOLOGICALS & BIOLOGNANA

Peer Comparison Chart


About Mercury Laboratories

Mercury Laboratories Limited, with Security Code 538964, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

A unique floating lab in San Francisco Bay has been invaded — and researchers are learning from it

(09 Jan 2025)
The structure won design awards, and has spent the past five years moored off the Port of Oakland, quietly collecting data from the Bay.
Read more →

Mercury Laboratories Receives 'Hold' Rating from MarketsMOJO, Strong Financial Position and Technical Trends Support Decision

(02 Dec 2024)
Mercury Laboratories, a microcap pharmaceutical company, has recently received a 'Hold' rating from MarketsMOJO on December 2, 2024.
Read more →

Mercury Laboratories Receives 'Sell' Rating from MarketsMOJO Due to Poor Growth and Lackluster Financial Results

(28 Nov 2024)
Mercury Laboratories, a microcap pharmaceutical company, has recently received a 'Sell' rating from MarketsMOJO. This downgrade is based on the company's...
Read more →

Mercury Labs Standalone September 2024 Net Sales at Rs 18.19 crore, down 20.04% Y-o-Y

(25 Nov 2024)
Quarterly Net Profit at Rs. 0.50 crore in September 2024 down 66.81% from Rs. 1.51 crore in September 2023.
Read more →

1181 Companies To Post Q2 Results Along With Hero MotoCorp, Hindustan Aeronautics, Reliance Infrastructure & Muthoot Finance: Check Out Full List Here

(21 Nov 2024)
Today's long list of 1181 companies posting results includes Hero MotoCorp, a two-wheeler manufacturer; Grasim Industries, the flagship business of the Aditya...
Read more →

Mercury Labs Reports Flat Performance in Q2, Lowest Operating Profit in 5 Quarters

(19 Nov 2024)
Mercury Laboratories, a microcap pharmaceutical company, recently announced its financial results for the quarter ending September 2024.
Read more →